drugset / Trial / NCT00037050

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

NCT00037050

Phase 3 Completed 739 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will treat patients who have a short term central catheter that is thought to be infected with a specific bacteria (gram positive bacteria)

Timeline

Start
2002-04
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dicloxacillin Small molecule
Subject Linezolid Other / unclassified
Subject Vancomycin Other / unclassified
Subject oxacillin Small molecule